TaiRx (ROCO:6580) FCF Margin % : -737.07% (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is TaiRx FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. TaiRx's Free Cash Flow for the six months ended in Dec. 2024 was NT$-58.65 Mil. TaiRx's Revenue for the six months ended in Dec. 2024 was NT$7.96 Mil. Therefore, TaiRx's FCF Margin % for the quarter that ended in Dec. 2024 was -737.07%.

As of today, TaiRx's current FCF Yield % is -5.40%.

The historical rank and industry rank for TaiRx's FCF Margin % or its related term are showing as below:

ROCO:6580' s FCF Margin % Range Over the Past 10 Years
Min: -12330.05 Med: -3840.95 Max: -1822.01
Current: -1822.01

During the past 10 years, the highest FCF Margin % of TaiRx was -1822.01%. The lowest was -12330.05%. And the median was -3840.95%.

ROCO:6580's FCF Margin % is ranked worse than
82.88% of 999 companies
in the Biotechnology industry
Industry Median: -120.51 vs ROCO:6580: -1822.01

TaiRx FCF Margin % Historical Data

The historical data trend for TaiRx's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiRx FCF Margin % Chart

TaiRx Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-4,238.49

-2,438.26

-2,686.44

-3,840.95

-1,825.92

TaiRx Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-1,625.84	-412,533.33	-1,651.83	-34,398.87	-737.07

Competitive Comparison of TaiRx's FCF Margin %

For the Biotechnology subindustry, TaiRx's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TaiRx's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiRx's FCF Margin % distribution charts can be found below:

* The bar in red indicates where TaiRx's FCF Margin % falls into.

Save Embed

;

Save Embed

;

TaiRx FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

TaiRx's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-150.127	/	8.222
	=	-1,825.92 %

TaiRx's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-58.649	/	7.957
	=	-737.07 %

TaiRx FCF Margin % Related Terms

Thank you for viewing the detailed overview of TaiRx's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiRx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiRx Inc (ROCO:6580) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 66, Sanchong Road, 1st Floor, 6th Floor, Nangang District, Taipei, TWN, 11502

Website

https://www.trx.com.tw

TaiRx Inc is a pharmaceutical company based in Taiwan. It develops new drugs and improves current standard treatments to promptly find cures for diseases and fulfill unmet medical needs. The company focuses on new drug development for Asia and other markets.

TaiRx Headlines

No Headlines